| 1. |
|
|
| 2. |
- Betancourt, Lazaro Hiram, et al.
(författare)
-
The human melanoma proteome atlas-Defining the molecular pathology
- 2021
-
Ingår i: Clinical and Translational Medicine. - : Wiley. - 2001-1326. ; 11:7, s. 1-20
-
Tidskriftsartikel (refereegranskat)abstract
- The MM500 study is an initiative to map the protein levels in malignant melanoma tumor samples, focused on in-depth histopathology coupled to proteome characterization. The protein levels and localization were determined for a broad spectrum of diverse, surgically isolated melanoma tumors originating from multiple body locations. More than 15,500 proteoforms were identified by mass spectrometry, from which chromosomal and subcellular localization was annotated within both primary and metastatic melanoma. The data generated by global proteomic experiments covered 72% of the proteins identified in the recently reported high stringency blueprint of the human proteome. This study contributes to the NIH Cancer Moonshot initiative combining detailed histopathological presentation with the molecular characterization for 505 melanoma tumor samples, localized in 26 organs from 232 patients.
|
|
| 3. |
- El-Tawil, Asmaa A., et al.
(författare)
-
Influence of Bio-Coal Properties on Carbonization and Bio-Coke Reactivity
- 2021
-
Ingår i: Metals. - : Minerals, Metals & Materials Society. - 2075-4701. ; 11:11
-
Tidskriftsartikel (refereegranskat)abstract
- Coke corresponds to 2/3–3/4 of the reducing agents in BF, and by the partial replacement of coking coals with 5–10% of bio-coal, the fossil CO2 emissions from the BF can be lowered by ~4–8%. Coking coal blends with 5% and 10% additions of bio-coals (pre-treated biomass) of different origins and pre-treatment degrees were carbonized at laboratory scale and with a 5% bio-coal addition at technical scale, aiming to understand the impact on the bio-coal properties (ash amount and composition, volatile matter content) and the addition of bio-coke reactivity. A thermogravimetric analyzer (TGA) connected to a quadrupole mass spectroscope monitored the residual mass and off-gases during carbonization. To explore the effect of bio-coal addition on plasticity, optical dilatometer tests were conducted for coking coal blends with 5% and 10% bio-coal addition. The plasticity was lowered with increasing bio-coal addition, but pyrolyzed biomass had a less negative effect on the plasticity compared to torrefied biomasses with a high content of oxygen. The temperature for starting the gasification of coke was in general lowered to a greater extent for bio-cokes produced from coking coal blends containing bio-coals with higher contents of catalyzing oxides. There was no significant difference in the properties of laboratory and technical scale produced coke, in terms of reactivity as measured by TGA. Bio-coke produced with 5% of high temperature torrefied pelletized biomass showed a similar coke strength as reference coke after reaction.
|
|
| 4. |
- El-Tawil, Asmaa, et al.
(författare)
-
Influence of Modified Bio-Coals on Carbonization and Bio-Coke Reactivity
- 2021
-
Ingår i: Metals. - : MDPI. - 2075-4701. ; 12:1
-
Tidskriftsartikel (refereegranskat)abstract
- Substitution of coal in coking coal blend with bio-coal is a potential way to reduce fossil CO2 emissions from iron and steelmaking. The current study aims to explore possible means to counteract negative influence from bio-coal in cokemaking. Washing and kaolin coating of bio-coals were conducted to remove or bind part of the compounds in the bio-coal ash that catalyzes the gasification of coke with CO2. To further explore how the increase in coke reactivity is related to more reactive carbon in bio-coal or catalytic oxides in bio-coal ash, ash was produced from a corresponding amount of bio-coal and added to the coking coal blend for carbonization. The reaction behavior of coals and bio-coals under carbonization conditions was studied in a thermogravimetric analyzer equipped with a mass spectrometer during carbonization. The impact of the bio-coal addition on the fluidity of the coking coal blend was studied in optical dilatometer tests for coking coal blends with and without the addition of bio-coal or bio-coal ash. The result shows that the washing of bio-coal will result in lower or even negative dilatation. The washing of bio-coals containing a higher amount of catalytic components will reduce the negative effect on bio-coke reactivity, especially with acetic acid washing when the start of gasification temperature is less lowered. The addition of bio-coal coated with 5% kaolin do not significantly lower the dilatation-relative reference coking coal blend. The reactivity of bio-cokes containing bio-coal coated with kaolin-containing potassium oxide was higher in comparison to bio-coke containing the original bio-coal. The addition of ash from 5% of torrefied bio-coals has a moderate effect on lowering the start of gasification temperature, which indicates that the reactive carbon originating from bio-coal has a larger impact.
|
|
| 5. |
- El-Tawil, Asmaa, et al.
(författare)
-
The Effect of Bio-Coal Agglomeration and High-Fluidity Coking Coal on Bio-Coke Quality
- 2023
-
Ingår i: Metals. - : MDPI. - 2075-4701. ; 13:1
-
Tidskriftsartikel (refereegranskat)abstract
- Metallurgical coke with high strength and low reactivity is used in the ironmaking blast furnace. Replacement of some coking coal with bio-coal was shown to result in lower strength and higher reactivity of produced coke due to introduction of reactive bio-coal carbon and ash components catalyzing the Boudouard reaction, but also due to lowering of the coking coal blend fluidity, which influences coke strength and reactivity negatively. The current study aims to investigate the possibility to counteract negative impact from bio-coal addition on fluidity and coke reactivity by using high-fluidity coking coal and by agglomeration of bio-coal before addition. Original bio-coal and micro-agglomerate of bio-coal was added at 10%, 15% and 20% to the coking coal blend. The influence of bio-coals on the coke reactivity was measured by using CO2 in a thermogravimetric analyzer. Selected cokes and bio-cokes were produced in technical scale, and their reactivity and strength were measured in standard tests. The effect on dilatation of adding bio-coal or crushed agglomerates of bio-coal to the coking coal blends was measured in an optical dilatometer. The results show that by using a coking coal blend containing high-fluidity coal with agglomerated bio-coal, the max. contraction is increased, whereas the opposite occurs by using original bio-coal. The results show overlapping between contraction occurring before dilatation and during dilation, which affects max. dilatation. The bio-coke containing high-fluidity coal with agglomerated bio-coal has lower reactivity in comparison to bio-cokes with original bio-coal or bio-coke with agglomerated bio-coal produced from a coking coal blend without high-fluidity coal. The reactivity of coke produced in technical scale, as measured in CRI/CSR tests, shows a similar trend regarding reactivity, as measured by thermogravimetric analysis, on coke produced in laboratory scale.
|
|
| 6. |
- Engström, Terese, et al.
(författare)
-
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
- 2024
-
Ingår i: Acta Oncologica. - 0284-186X. ; 63, s. 125-136
-
Tidskriftsartikel (refereegranskat)abstract
- Background and purpose: Tamoxifen remains an important adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Thus, determination of hormone receptors is important. Here, we compare cytosol-based methods, immunohistochemistry (IHC), and gene expression (GEX) analysis for determining hormone receptor status in premenopausal breast cancer patients from a randomised tamoxifen trial, to evaluate their performance in identifying patients that benefit from tamoxifen. Patients and Methods: Premenopausal patients (n=564) were randomised to 2 years of tamoxifen or no systemic treatment. Estrogen receptor (ER) and progesterone receptor (PR) status by protein expression measured by cytosol-based methods and IHC, and mRNA by GEX analysis were compared in 313 patients with available data from all methods. Kaplan Meier estimates and Cox regression were used to evaluate the treatment-predictive value for recurrence-free interval (RFi) and overall survival (OS). Median follow-up for event-free patients was 26 (RFi) and 33 (OS) years. Results: The mRNA data of ESR1 and PGR distributed bimodally, patterns confirmed in an independent cohort. Kappa-values between all methods were 0.76 and 0.79 for ER and PR, respectively. Tamoxifen improved RFi in patients with ER-positive (ER+) or PR-positive (PR+) tumours (Hazard Ratio [HR] and 95% confidence interval [CI]), cytosol-ER+ 0.53 [0.36–0.79]; IHC-ER+ 0.55 [0.38–0.79]; GEX-ER+ 0.54 [0.37–0.77]; cytosol-PR+ 0.49 [0.34–0.72]; IHC-PR+ 0.58 [0.40–0.85]; GEX-PR+ 0.55 [0.38–0.80]). Results were similar for OS. Interpretation: These methods can all identify patients that benefit from 2 years of tamoxifen with equal performance, indicating that GEX data might be used to guide adjuvant tamoxifen therapy.
|
|
| 7. |
|
|
| 8. |
- Johansson, Patrik, et al.
(författare)
-
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
- 2020
-
Ingår i: Cell Reports. - : Elsevier BV. - 2211-1247. ; 32:2
-
Tidskriftsartikel (refereegranskat)abstract
- Glioblastoma (GBM) is a malignant brain tumor with few therapeutic options. The disease presents with a complex spectrum of genomic aberrations, but the pharmacological consequences of these aberrations are partly unknown. Here, we report an integrated pharmacogenomic analysis of 100 patient-derived GBM cell cultures from the human glioma cell culture (HGCC) cohort. Exploring 1,544 drugs, we find that GBM has two main pharmacological subgroups, marked by differential response to proteasome inhibitors and mutually exclusive aberrations in TP53 and CDKN2A/B. We confirm this trend in cell and in xenotransplantation models, and identify both Bcl-2 family inhibitors and p53 activators as potentiators of proteasome inhibitors in GBM cells, We can further predict the responses of individual cell cultures to several existing drug classes, presenting opportunities for drug repurposing and design of stratified trials. Our functionally profiled biobank provides a valuable resource for the discovery of new treatments for GBM.
|
|
| 9. |
- Kim, Yonghyo, et al.
(författare)
-
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
- 2020
-
Ingår i: Cancers. - : MDPI AG. - 2072-6694. ; 12:3
-
Forskningsöversikt (refereegranskat)abstract
- Malignant melanoma is among the most aggressive skin cancers and it has among the highest metastatic potentials. Although surgery to remove the primary tumor is the gold standard treatment, once melanoma progresses and metastasizes to the lymph nodes and distal organs, i.e., metastatic melanoma (MM), the usual outcome is decreased survival. To improve survival rates and life span, advanced treatments have focused on the success of targeted therapies in the MAPK pathway that are based on BRAF (BRAF V600E) and MEK. The majority of patients with tumors that have higher expression of BRAF V600E show poorer prognosis than patients with a lower level of the mutated protein. Based on the molecular basis of melanoma, these findings are supported by distinct tumor phenotypes determined from differences in tumor heterogeneity and protein expression profiles. With these aspects in mind, continued challenges are to: (1) deconvolute the complexity and heterogeneity of MM; (2) identify the signaling pathways involved; and (3) determine protein expression to develop targeted therapies. Here, we provide an overview of the results from protein expression in MM and the link to disease presentation in a variety of tumor phenotypes and how these will overcome the challenges of clinical problems and suggest new promising approaches in metastatic melanoma and cancer therapy.
|
|
| 10. |
- Lundgren, Anna Sofia, 1972-, et al.
(författare)
-
"For the good of the village" : volunteer initiatives and rural resilience
- 2023
-
Ingår i: Journal of Rural Studies. - : Elsevier. - 0743-0167 .- 1873-1392. ; 102
-
Tidskriftsartikel (refereegranskat)abstract
- As a consequence of cutbacks in the welfare sector, rural populations have reacted to their situation by taking over and operating activities that are threatened by closures, such as schools, grocery stores and health centres, for themselves. Such initiatives are often referred to as examples of rural resilience. Drawing on interviews, this paper explores participants' narratives about rural initiatives aiming to retain and develop local welfare and community services. It pays specific heed to how notions of resilience reside within the narratives – the ideological convictions and challenges they entail, and the practices they make (im)possible. The study shows that participants’ narratives about resilient villages and initiatives indirectly support the neoliberal rural policy focus on regional responsibility to create growth. It argues that, in order to understand the appeal of the neoliberal positions and practices that resilience thinking proved to entail, it is important to recognise the intersections of space and identity, and to explore the local spatial experiences and imageries in relation to which resilience practices appear desirable and necessary, as well as the specific rural identities that resilience discourse supports.
|
|
